CVS Health (NYSE:CVS) Shares Down 0.6% – Time to Sell?

CVS Health Co. (NYSE:CVS)’s share price was down 0.6% during mid-day trading on Tuesday . The company traded as low as $50.93 and last traded at $51.22. Approximately 3,163,712 shares traded hands during mid-day trading, a decline of 77% from the average daily volume of 13,606,966 shares. The stock had previously closed at $51.52.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of research reports. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research report on Tuesday, October 1st. Barclays reduced their price target on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a report on Thursday, November 7th. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price for the company in a research report on Tuesday, December 3rd. Finally, Piper Sandler cut their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $68.71.

CVS Health Trading Down 0.6 %

The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $64.44 billion, a P/E ratio of 13.00, a price-to-earnings-growth ratio of 0.85 and a beta of 0.59. The business has a fifty day moving average price of $51.76 and a 200 day moving average price of $56.49.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the previous year, the firm posted $2.21 EPS. On average, analysts expect that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 5.19%. CVS Health’s dividend payout ratio is currently 67.51%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Thurston Springer Miller Herd & Titak Inc. boosted its position in shares of CVS Health by 16.6% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 9,101 shares of the pharmacy operator’s stock worth $409,000 after acquiring an additional 1,296 shares in the last quarter. Park Avenue Securities LLC boosted its holdings in shares of CVS Health by 5.8% in the 4th quarter. Park Avenue Securities LLC now owns 24,646 shares of the pharmacy operator’s stock valued at $1,106,000 after purchasing an additional 1,359 shares in the last quarter. Oak Thistle LLC acquired a new position in shares of CVS Health during the 4th quarter worth $837,000. Mendota Financial Group LLC lifted its position in shares of CVS Health by 32,600.0% during the 4th quarter. Mendota Financial Group LLC now owns 981 shares of the pharmacy operator’s stock worth $44,000 after buying an additional 978 shares during the last quarter. Finally, Grandview Asset Management LLC bought a new position in CVS Health in the fourth quarter valued at about $311,000. Institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.